Amgen CEO Bob Bradway (L) and Bristol Myers Squibb CEO Giovanni Caforio
Amgen's Bob Bradway takes slight salary dip amid higher pay among US execs
Amgen released its executive compensation numbers late last week, and while the filing trailed behind other Big Pharmas and biotech companies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
